Human Med is committed to climate-friendly mobility. Strengthening the green and sustainable transformation within the company is part of this commitment.
When expanding Human Med’s vehicle fleet, the focus was placed on eliminating local CO2 emissions when purchasing new vehicles and replacing existing ones. In accordance with the German government’s funding guideline, Human Med took into account the switch to e-mobility when purchasing new vehicles. For this, Human Med received EU funding after approval from the Federal Office of Economics and Export Control (BAFA) and was able to make a contribution to the transport transition at the Schwerin site and in Germany.